UPDATE 1-Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook [Reuters]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Reuters
Johnson & Johnson beats profit estimates on pharma strength, raises sales outlook (Reuters) - Johnson & Johnson ( JNJ.N Overall strength in J&J’s pharmaceuticals unit, bolstered by recent approvals for new treatments such as its cancer drug Erleada also helped drive its earnings beat. Pharmaceutical sales rose 1.7% to $10.53 billion, above analysts’ estimates of $10.27 billion, according to three analysts polled by Refinitiv. The company raised its operational sales forecast for 2019 to $82.4 billion to $83.2 billion, from a prior range of $82 billion to $82.8 billion. The diversified healthcare company, the first major U.S. drugmaker to report second-quarter results, said net earnings rose to $5.61 billion, or $2.08 per share, from $3.95 billion, or $1.45 per share, a year earlier. Excluding items, the company earned $2.58 per share, beating analysts’ expectations for $2.46 per share, according to IBES data from Refinitiv. The company reported a quarterly litigation expense of $409 m
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- With Lawsuit And Medtech Tailwinds - Johnson & Johnson May Be Back [Seeking Alpha]Seeking Alpha
- Manifest Technologies Emerges From Stealth With Strategic Investors and Prepares for Next Development Stage of AI-Powered Precision Neuroscience [Yahoo! Finance]Yahoo! Finance
- The Road To A Decentralized Work Life [Forbes]Forbes
- Global Bariatric Surgery Market Analysis Report 2024-2033: Addressing Obesity's Impact Extending Beyond Weight Concerns [Yahoo! Finance]Yahoo! Finance
- J&J can contest evidence linking its talc to cancer, judge rules [CNBC]CNBC
JNJ
Earnings
- 1/23/24 - Beat
JNJ
Sec Filings
- 3/27/24 - Form PX14A6G
- 3/13/24 - Form 4
- 3/13/24 - Form 144
- JNJ's page on the SEC website